101 testsMean quarterly HBV tests were 101 ± 3 during July–September in Freetown, Sierra Leone.
Sierra Leonehépatite Bobserved July-Septemberpublished 2023Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Phaeurope_pmcdocument of 8 observationsDOI 10.1101/2023.05.24.23290418
The highest incidence of Lassa fever in Sierra Leone was observed during the dry season.
Sierra Leonefièvre de Lassapublished 2014PLoS neglected tropical diseaseseurope_pmcdocument of 6 observations
28.1 %Among children and adolescents in Sierra Leone, Y181C/V/I was found in 28.1% (n = 18/64) of cases.
Sierra LeoneVIH/sidapublished 2021Geneseurope_pmcdocument of 21 observationsDOI 10.3390/genes12091314
6 aORRenal impairment was associated with hypertension among people living with HIV, with an adjusted odds ratio of 6.00.
Sierra Leonehypertension artérielle · renal impairmentpublished 2022Journal of clinical medicineeurope_pmcdocument of 9 observations
412 cells/mm³The median CD4 count among enrolled people with HIV in Freetown, Sierra Leone was 412 cells/mm³.
Sierra LeoneVIH/sidaobserved April to June 2022published 2023Vaccineseurope_pmcdocument of 5 observationsDOI 10.3390/vaccines11111685
13.4 %The prevalence of smoking among adults in Freetown, Sierra Leone was 13.4%.
Sierra Leonesmokingobserved 2019–2021published 2023Burden of cardiometabolic risk factors and preclinical target organ damage among adults ineurope_pmcdocument of 8 observationsDOI 10.1101/2023.02.20.23286145
75 %Antivirals were used in 75% of the articles on COVID-19 patients with sepsis or septic shock.
Sierra LeoneCOVID-19 · sepsis · septic shockpublished 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument of 17 observationsDOI 10.21203/rs.3.rs-30474/v1
26.4 %Among 197 patients with chronic respiratory symptoms in an urban tertiary hospital in Sierra Leone, 52 (26.4%) were HIV positive.
Sierra LeoneVIH/sidaobserved November 2021 to July 2022published 2023PLoS neglected tropical diseaseseurope_pmcdocument of 9 observations
59.5 %Among healthcare professionals in Sierra Leone surveyed from January to March 2022, 59.5% reported a preference for natural immunity regarding COVID-19 vaccines.
Sierra LeoneCOVID-19observed January to March 2022published 2022Vaccineseurope_pmcdocument of 12 observations
The case fatality rate of ribavirin-treated patients presenting early in acute infection was lower than in untreated subjects.
Sierra Leonefièvre de Lassapublished 2014PLoS neglected tropical diseaseseurope_pmcdocument of 6 observations
5,000 adultsIn Sierra Leone, there are an estimated 5000 adults with allergic bronchopulmonary aspergillosis complicating asthma.
Sierra Leoneallergic bronchopulmonary aspergillosis · asthmepublished 2021Therapeutic advances in infectious diseaseeurope_pmcdocument of 9 observations
33 %Of the gram-negative bacteria, 33% were Carbapenem-resistant Pseudomonas aeruginosa.
Sierra LeoneCarbapenem-resistant Pseudomonas aeruginosapublished 2022Therapeutic advances in infectious diseaseeurope_pmcdocument of 6 observations
52.2 %Among 306 adult participants in Freetown, Sierra Leone, 52.2% had good HBV knowledge.
Sierra Leonehépatite Bpublished 2023Healthcare (Basel, Switzerland)europe_pmcdocument of 5 observationsDOI 10.3390/healthcare11020177
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.